 Dirk Haselow
Concepts (200)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disease Outbreaks | 11 | 2021 | 125 | 2.480 |
Why?
| | Mumps | 5 | 2021 | 14 | 1.850 |
Why?
| | Arkansas | 20 | 2022 | 1977 | 1.100 |
Why?
| | Immunization Programs | 3 | 2016 | 23 | 1.090 |
Why?
| | Mumps virus | 3 | 2021 | 12 | 1.020 |
Why?
| | Histoplasmosis | 3 | 2018 | 50 | 0.980 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2020 | 20 | 0.730 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2019 | 5 | 0.660 |
Why?
| | School Health Services | 2 | 2016 | 49 | 0.630 |
Why?
| | Sepsis | 1 | 2020 | 220 | 0.600 |
Why?
| | Vaccination | 2 | 2019 | 266 | 0.600 |
Why?
| | Clinical Laboratory Techniques | 1 | 2017 | 30 | 0.600 |
Why?
| | Lyme Disease | 1 | 2017 | 32 | 0.590 |
Why?
| | Absenteeism | 1 | 2016 | 17 | 0.540 |
Why?
| | Smallpox | 1 | 2015 | 3 | 0.520 |
Why?
| | Smallpox Vaccine | 1 | 2015 | 2 | 0.520 |
Why?
| | Immunity, Humoral | 1 | 2015 | 22 | 0.510 |
Why?
| | Bambusa | 1 | 2014 | 2 | 0.470 |
Why?
| | Fires | 1 | 2014 | 13 | 0.470 |
Why?
| | Pertussis Vaccine | 1 | 2013 | 3 | 0.460 |
Why?
| | Whooping Cough | 1 | 2013 | 13 | 0.460 |
Why?
| | Communicable Disease Control | 1 | 2013 | 39 | 0.450 |
Why?
| | Endemic Diseases | 2 | 2018 | 22 | 0.440 |
Why?
| | Medical Informatics Applications | 1 | 2013 | 7 | 0.440 |
Why?
| | Mandatory Reporting | 1 | 2013 | 12 | 0.430 |
Why?
| | Coccidioidomycosis | 1 | 2012 | 6 | 0.410 |
Why?
| | Cooperative Behavior | 1 | 2013 | 228 | 0.400 |
Why?
| | Blastomycosis | 1 | 2012 | 62 | 0.400 |
Why?
| | Neoplasms | 1 | 2020 | 1235 | 0.370 |
Why?
| | Internet | 1 | 2013 | 259 | 0.360 |
Why?
| | Humans | 32 | 2022 | 49974 | 0.360 |
Why?
| | Incidence | 4 | 2019 | 1003 | 0.310 |
Why?
| | Population Surveillance | 2 | 2018 | 164 | 0.270 |
Why?
| | Influenza, Human | 2 | 2016 | 84 | 0.240 |
Why?
| | Male | 15 | 2019 | 25241 | 0.240 |
Why?
| | Child, Preschool | 6 | 2021 | 3871 | 0.230 |
Why?
| | Environmental Exposure | 3 | 2001 | 199 | 0.220 |
Why?
| | Adolescent | 7 | 2021 | 6356 | 0.220 |
Why?
| | Female | 13 | 2019 | 26472 | 0.210 |
Why?
| | Fishes | 2 | 2001 | 20 | 0.210 |
Why?
| | Adult | 11 | 2021 | 13236 | 0.210 |
Why?
| | Hot Springs | 1 | 2022 | 1 | 0.200 |
Why?
| | Legionella pneumophila | 1 | 2022 | 5 | 0.200 |
Why?
| | Legionnaires' Disease | 1 | 2022 | 3 | 0.200 |
Why?
| | Methotrexate | 1 | 2022 | 69 | 0.200 |
Why?
| | Water Supply | 3 | 2022 | 22 | 0.200 |
Why?
| | Pfiesteria piscicida | 1 | 2001 | 2 | 0.200 |
Why?
| | Aged, 80 and over | 6 | 2019 | 3129 | 0.190 |
Why?
| | Middle Aged | 9 | 2021 | 12069 | 0.190 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2020 | 12 | 0.190 |
Why?
| | Genotype | 2 | 2019 | 537 | 0.190 |
Why?
| | Child | 6 | 2021 | 6847 | 0.180 |
Why?
| | Outpatients | 1 | 2020 | 113 | 0.170 |
Why?
| | Antibodies, Viral | 2 | 2019 | 88 | 0.170 |
Why?
| | Serologic Tests | 1 | 2019 | 26 | 0.160 |
Why?
| | Burkholderia Infections | 1 | 2018 | 4 | 0.160 |
Why?
| | Burkholderia | 1 | 2018 | 11 | 0.160 |
Why?
| | Young Adult | 5 | 2021 | 3958 | 0.160 |
Why?
| | Wound Infection | 1 | 2018 | 27 | 0.160 |
Why?
| | Chagas Disease | 1 | 2018 | 3 | 0.160 |
Why?
| | Infant | 4 | 2021 | 3567 | 0.160 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2019 | 181 | 0.160 |
Why?
| | Histoplasma | 1 | 2018 | 27 | 0.150 |
Why?
| | Emigrants and Immigrants | 1 | 2018 | 35 | 0.150 |
Why?
| | Genome, Bacterial | 1 | 2018 | 125 | 0.150 |
Why?
| | Babesiosis | 1 | 2017 | 6 | 0.150 |
Why?
| | Public Health | 2 | 2019 | 204 | 0.140 |
Why?
| | Water Wells | 1 | 2016 | 1 | 0.140 |
Why?
| | Droughts | 1 | 2016 | 8 | 0.140 |
Why?
| | Ticks | 1 | 2016 | 7 | 0.140 |
Why?
| | Ownership | 1 | 2016 | 17 | 0.140 |
Why?
| | Tick-Borne Diseases | 1 | 2016 | 6 | 0.140 |
Why?
| | Cause of Death | 1 | 1997 | 143 | 0.140 |
Why?
| | Transients and Migrants | 1 | 2016 | 24 | 0.140 |
Why?
| | Blood Transfusion | 1 | 2017 | 121 | 0.130 |
Why?
| | Cryptococcosis | 1 | 2015 | 20 | 0.130 |
Why?
| | Cryptococcus neoformans | 1 | 2015 | 27 | 0.130 |
Why?
| | Medical Staff, Hospital | 1 | 2015 | 14 | 0.130 |
Why?
| | Tuberculosis | 1 | 2016 | 146 | 0.130 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2015 | 23 | 0.130 |
Why?
| | Education, Medical, Continuing | 1 | 2015 | 68 | 0.130 |
Why?
| | Influenza Vaccines | 1 | 2015 | 30 | 0.130 |
Why?
| | Nursing Staff, Hospital | 1 | 2015 | 33 | 0.130 |
Why?
| | Aged | 6 | 2019 | 9310 | 0.130 |
Why?
| | Regression Analysis | 1 | 2016 | 395 | 0.120 |
Why?
| | Mycobacterium tuberculosis | 1 | 2016 | 285 | 0.120 |
Why?
| | Salmonella Food Poisoning | 1 | 2014 | 6 | 0.120 |
Why?
| | Salmonella | 1 | 2014 | 26 | 0.120 |
Why?
| | Hepatitis C, Chronic | 1 | 2015 | 83 | 0.120 |
Why?
| | School Nursing | 1 | 2013 | 10 | 0.120 |
Why?
| | Prisons | 1 | 2014 | 38 | 0.110 |
Why?
| | Prostatic Neoplasms | 1 | 1997 | 394 | 0.110 |
Why?
| | Health Personnel | 1 | 2015 | 246 | 0.100 |
Why?
| | United States | 6 | 2022 | 4860 | 0.100 |
Why?
| | Fish Diseases | 2 | 2001 | 3 | 0.090 |
Why?
| | Genome, Viral | 2 | 2021 | 79 | 0.090 |
Why?
| | Water Microbiology | 2 | 2022 | 29 | 0.080 |
Why?
| | Treatment Outcome | 1 | 2019 | 5141 | 0.080 |
Why?
| | Phylogeny | 2 | 2019 | 235 | 0.080 |
Why?
| | Hip Fractures | 1 | 2008 | 47 | 0.080 |
Why?
| | Diarrhea | 2 | 2014 | 92 | 0.080 |
Why?
| | Chickenpox Vaccine | 1 | 2006 | 5 | 0.070 |
Why?
| | Chickenpox | 1 | 2006 | 18 | 0.070 |
Why?
| | Social Support | 1 | 2008 | 263 | 0.070 |
Why?
| | Case-Control Studies | 2 | 2014 | 1131 | 0.060 |
Why?
| | Mortality | 2 | 2001 | 99 | 0.060 |
Why?
| | Neuropsychological Tests | 2 | 2001 | 353 | 0.050 |
Why?
| | Animals | 6 | 2016 | 13187 | 0.050 |
Why?
| | Methylmercury Compounds | 1 | 2001 | 6 | 0.050 |
Why?
| | Inhalation Exposure | 1 | 2001 | 32 | 0.050 |
Why?
| | Pharyngitis | 1 | 2001 | 16 | 0.050 |
Why?
| | Water | 1 | 2022 | 77 | 0.050 |
Why?
| | Nausea | 1 | 2001 | 50 | 0.050 |
Why?
| | Washington | 1 | 2021 | 43 | 0.050 |
Why?
| | Headache | 1 | 2001 | 76 | 0.050 |
Why?
| | Eye Diseases | 1 | 2001 | 38 | 0.050 |
Why?
| | Aerosols | 1 | 2001 | 73 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2015 | 1557 | 0.050 |
Why?
| | Abdominal Pain | 1 | 2001 | 81 | 0.050 |
Why?
| | Micronesia | 1 | 2021 | 107 | 0.050 |
Why?
| | Cohort Studies | 3 | 2015 | 1422 | 0.050 |
Why?
| | Cell Movement | 1 | 2001 | 247 | 0.050 |
Why?
| | Biopsy | 1 | 2022 | 584 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 218 | 0.040 |
Why?
| | Occupational Exposure | 1 | 2001 | 122 | 0.040 |
Why?
| | Mumps Vaccine | 1 | 2019 | 6 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2018 | 2772 | 0.040 |
Why?
| | Neutralization Tests | 1 | 2019 | 24 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2019 | 64 | 0.040 |
Why?
| | Multilocus Sequence Typing | 1 | 2018 | 14 | 0.040 |
Why?
| | Bacterial Typing Techniques | 1 | 2018 | 39 | 0.040 |
Why?
| | Trypanosoma cruzi | 1 | 2018 | 3 | 0.040 |
Why?
| | Latin America | 1 | 2018 | 9 | 0.040 |
Why?
| | Emigration and Immigration | 1 | 2018 | 17 | 0.040 |
Why?
| | Amnesia | 1 | 1998 | 8 | 0.040 |
Why?
| | Dinoflagellida | 1 | 1998 | 5 | 0.040 |
Why?
| | Geography, Medical | 1 | 2018 | 5 | 0.040 |
Why?
| | Public Health Surveillance | 1 | 2018 | 13 | 0.040 |
Why?
| | Neurons | 1 | 2001 | 460 | 0.040 |
Why?
| | History, 21st Century | 1 | 2018 | 56 | 0.040 |
Why?
| | Quinine | 1 | 2017 | 5 | 0.040 |
Why?
| | Babesia | 1 | 2017 | 5 | 0.040 |
Why?
| | Clindamycin | 1 | 2017 | 13 | 0.040 |
Why?
| | Wisconsin | 1 | 1997 | 45 | 0.040 |
Why?
| | Platelet Transfusion | 1 | 2017 | 28 | 0.040 |
Why?
| | Doxycycline | 1 | 2017 | 32 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2017 | 195 | 0.040 |
Why?
| | Liver | 1 | 2022 | 1115 | 0.030 |
Why?
| | Water Quality | 1 | 2016 | 6 | 0.030 |
Why?
| | Communicable Diseases, Emerging | 1 | 2016 | 11 | 0.030 |
Why?
| | Risk Factors | 3 | 2015 | 3613 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 235 | 0.030 |
Why?
| | Bird Diseases | 1 | 2015 | 2 | 0.030 |
Why?
| | Birds | 1 | 2015 | 12 | 0.030 |
Why?
| | Hospitals, Community | 1 | 2015 | 17 | 0.030 |
Why?
| | Uridine Monophosphate | 1 | 2015 | 4 | 0.030 |
Why?
| | Hepatitis C Antibodies | 1 | 2015 | 20 | 0.030 |
Why?
| | Ribavirin | 1 | 2015 | 15 | 0.030 |
Why?
| | Focus Groups | 1 | 2016 | 190 | 0.030 |
Why?
| | Drug Costs | 1 | 2015 | 39 | 0.030 |
Why?
| | Serotyping | 1 | 2014 | 12 | 0.030 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2014 | 29 | 0.030 |
Why?
| | Food Contamination | 1 | 2014 | 40 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2015 | 222 | 0.030 |
Why?
| | Food Handling | 1 | 2014 | 33 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2015 | 173 | 0.030 |
Why?
| | Hospitalization | 1 | 2018 | 652 | 0.030 |
Why?
| | Feces | 1 | 2014 | 134 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 903 | 0.030 |
Why?
| | Maryland | 2 | 2001 | 33 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2015 | 6108 | 0.020 |
Why?
| | Prospective Studies | 2 | 2008 | 2364 | 0.020 |
Why?
| | Baltimore | 1 | 2008 | 29 | 0.020 |
Why?
| | Friends | 1 | 2008 | 17 | 0.020 |
Why?
| | Family | 1 | 2008 | 170 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2008 | 402 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2008 | 577 | 0.020 |
Why?
| | Survival Rate | 1 | 2008 | 894 | 0.020 |
Why?
| | Schools | 1 | 2006 | 165 | 0.020 |
Why?
| | DNA, Protozoan | 1 | 2001 | 12 | 0.010 |
Why?
| | Virginia | 1 | 2001 | 17 | 0.010 |
Why?
| | Fisheries | 1 | 2001 | 7 | 0.010 |
Why?
| | North Carolina | 1 | 2001 | 52 | 0.010 |
Why?
| | Interleukin-1 | 1 | 2001 | 104 | 0.010 |
Why?
| | Ecosystem | 1 | 2001 | 64 | 0.010 |
Why?
| | Drug Interactions | 1 | 2001 | 206 | 0.010 |
Why?
| | Cerebellum | 1 | 2001 | 135 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2001 | 367 | 0.010 |
Why?
| | Escherichia coli | 1 | 2001 | 186 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2001 | 192 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2001 | 242 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 595 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2001 | 264 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2001 | 388 | 0.010 |
Why?
| | Hotlines | 1 | 1998 | 16 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2001 | 1105 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 1573 | 0.010 |
Why?
| | Risk Assessment | 1 | 2001 | 1259 | 0.010 |
Why?
| | Signal Transduction | 1 | 2001 | 1618 | 0.010 |
Why?
| | Mice | 1 | 2001 | 5739 | 0.010 |
Why?
|
|
Haselow's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|